Trial Profile
Prevention of ischemia/reperfusion injury by C1 INH. Assessment of reperfusion injury in total knee arthroplasty: pilot study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2022
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Reperfusion injury
- Focus Therapeutic Use
- 01 Jan 2021 Status changed from active, no longer recruiting to completed.
- 06 Sep 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2020.
- 06 Sep 2018 Status changed from active, no longer recruiting to recruiting.